Restenosis
KEYWORDS: stent, des, vessel, coronary, drug, restenosis, isr, factors, bms, re-stenosis, response, wall, inflammatory, clinical, formation

stent (BMS) should be treated with drug eluting stent (DES) if anatomic factors are appropriate and the patient is able to comply with and tolerate dual antiplatelet therapy (DAPT).[27][28][29](Level of Evidence: A)" 9/10 Class III (No Benefit) "1. Patients who develop clinical restenosis after drug eluting stent (DES) may be considered for repeat PCI with balloon angioplasty, bare metal stent (BMS), or drug eluting stent (DES) containing the same drug or an alternative antiproliferative drug if anatomic factors are appropriate and the patient is able to comply with and tolerate dual antiplatelet therapy (DAPT).[1] (Level of Evidence: C)" Class IIa "1. IVUS is reasonable to determine the mechanism of stent restenosis.[1] (Level of Evidence: C)" Related Chapters â€¢ Drug-eluting stent
